Filtered By:
Source: Molecular Pharmaceutics
Cancer: Ovarian Cancer
This page shows you your search results in order of date.
Order by Relevance | Date
Total 2 results found since Jan 2013.
Mechanistic Nanotherapeutic Approach Based on siRNA-Mediated
DJ-1 Protein Suppression for Platinum-Resistant Ovarian Cancer
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.6b00205
Source: Molecular Pharmaceutics - May 26, 2016 Category: Drugs & Pharmacology Authors: Canan Schumann, Stephanie Chan, Oleh Khalimonchuk, Shannon Khal, Vitaliya Moskal, Vidhi Shah, Adam W. G. Alani, Olena Taratula and Oleh Taratula Source Type: research
Chitosan Coated Polylactic Acid Nanoparticle-Mediated
Combinatorial Delivery of Cisplatin and siRNA/Plasmid DNA Chemosensitizes
Cisplatin-Resistant Human Ovarian Cancer Cells
Molecular PharmaceuticsDOI: 10.1021/mp500259e
Source: Molecular Pharmaceutics - June 20, 2014 Category: Drugs & Pharmacology Authors: Anish Babu, Qi Wang, Ranganayaki Muralidharan, Manish Shanker, Anupama Munshi and Rajagopal Ramesh Source Type: research
